Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 8 | 2024 | 3589 | 1.410 |
Why?
|
Myelodysplastic Syndromes | 4 | 2024 | 1376 | 0.900 |
Why?
|
Cytokine-Induced Killer Cells | 1 | 2019 | 6 | 0.680 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 618 | 0.670 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5551 | 0.490 |
Why?
|
HLA Antigens | 1 | 2019 | 1334 | 0.450 |
Why?
|
Antigen Presentation | 1 | 2019 | 1237 | 0.450 |
Why?
|
Immunoconjugates | 1 | 2019 | 865 | 0.410 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1989 | 0.380 |
Why?
|
Tissue Donors | 1 | 2019 | 2228 | 0.340 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5785 | 0.310 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1864 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11587 | 0.280 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2023 | 93 | 0.210 |
Why?
|
Recurrence | 4 | 2023 | 8420 | 0.210 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5110 | 0.210 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2022 | 1517 | 0.200 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13550 | 0.180 |
Why?
|
Mitoxantrone | 1 | 2019 | 150 | 0.170 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 115 | 0.170 |
Why?
|
Maximum Tolerated Dose | 2 | 2019 | 871 | 0.170 |
Why?
|
Azacitidine | 2 | 2023 | 336 | 0.160 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6780 | 0.160 |
Why?
|
Etoposide | 1 | 2019 | 626 | 0.150 |
Why?
|
Cytarabine | 1 | 2019 | 696 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2019 | 388 | 0.150 |
Why?
|
Antifungal Agents | 1 | 2020 | 711 | 0.130 |
Why?
|
Eosinophilia | 1 | 2020 | 556 | 0.130 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 88 | 0.130 |
Why?
|
Retreatment | 1 | 2015 | 600 | 0.110 |
Why?
|
Silymarin | 1 | 2013 | 44 | 0.110 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4876 | 0.100 |
Why?
|
Phosphatidylcholines | 1 | 2013 | 406 | 0.100 |
Why?
|
Thalidomide | 1 | 2015 | 883 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 2964 | 0.090 |
Why?
|
Genotype | 1 | 2023 | 12869 | 0.080 |
Why?
|
Chronic Disease | 1 | 2023 | 9162 | 0.080 |
Why?
|
Humans | 16 | 2024 | 752411 | 0.080 |
Why?
|
Adult | 6 | 2023 | 216927 | 0.070 |
Why?
|
Aged | 5 | 2020 | 166585 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9101 | 0.070 |
Why?
|
Middle Aged | 6 | 2020 | 217039 | 0.070 |
Why?
|
Proteomics | 1 | 2019 | 3751 | 0.070 |
Why?
|
Antioxidants | 1 | 2013 | 1651 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2902 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58299 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2022 | 2495 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5164 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12745 | 0.060 |
Why?
|
Male | 7 | 2022 | 354908 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2023 | 79133 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2022 | 1572 | 0.050 |
Why?
|
Neoplasms | 2 | 2021 | 21806 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 158 | 0.050 |
Why?
|
Female | 5 | 2020 | 386085 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2013 | 2269 | 0.050 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2023 | 636 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18298 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17647 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4271 | 0.040 |
Why?
|
Young Adult | 2 | 2020 | 57632 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2412 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2023 | 64250 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15622 | 0.030 |
Why?
|
Pyrazoles | 1 | 2020 | 1984 | 0.020 |
Why?
|
Pyrimidines | 1 | 2020 | 2979 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4601 | 0.020 |
Why?
|
Incidence | 1 | 2020 | 21157 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10796 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29337 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23788 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13405 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29706 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 73425 | 0.010 |
Why?
|
Concepts
(74)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_